Safety and Immunogenicity of an Adjuvanted Trivalent Influenza Vaccine in Children 6 to <72 Months of Age in Mexico.
Clinical trial NCT02255279 · COMPLETED
Trial details
- NCT number
- NCT02255279
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2015-05-01
- Enrollment
- 287
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.